Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings WiderThanExpected Loss as Clinical Pipeline Progresses RSG Q1 2026 Earnings EPS Beat Driven by Operational Efficiency Pasithea Therapeutics Corp KTTA Q1 2026 Earnings Significant EPS Beat Despite Zero Revenue BHB Q1 2026 Earnings EPS Misses Estimates Shares Edge Higher CHA Q4 2025 Earnings EPS Misses Estimates by Wide Margin TATT Q1 2026 Earnings Strong EPS Beat Signals Momentum in Aerospace Defense